In this issue of Angiology, Rizk et al assess the association of adiponectin gene polymorphisms and, in particular, rs2241766 (þT45G) and rs1501299 (þG276T), with adiponectin levels and with the risk of acute coronary syndrome (ACS) in an Arabian cohort of Qatar. 1 Despite the study's limitations, such as the small sample size, the small proportion of females, and its cross-sectional nature, the authors concluded that only the single-nucleotide polymorphism (SNP) T45G (and not SNP G276T) was associated with ACS. Among the various genotypes of T45G, the GG carriers were associated with a higher risk of developing an ACS and having lower adiponectin levels. Some parameters were also addressed, such as diabetes mellitus (DM), number of blood vessels affected, and the ejection fraction status in ACS, but no association with the genotype distributions of T45G or G276T polymorphisms was found, except for EF with T45G. 1 This editorial considers some additional aspects of this topic.
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Adiponectin and Cardiometabolic Risk
Adiponectin is a 30-kDa protein secreted by mature adipocytes. It belongs to the soluble collagen superfamily, exerting structural homology with collagen VIII and X, complement factor C1q, and the tumor necrosis factor family. 2 It is composed of a carboxyl-terminal globular domain and an amino-terminal collagenous domain, a structure that facilitates the formation of multimers. These include low-molecular-weight trimers, middle-molecular-weight 6-mers, and high-molecular-weight (HMW) 18-mers. 2 Adiponectin seems to play a key role in the atherosclerotic process, since it inhibits monocyte adhesion to endothelial cells and suppresses lipid accumulation in human monocyte-derived macrophages, thus inhibiting macrophage-to-foam cell transformation. 3 Adiponectin also exerts anti-inflammatory and insulinsensitizing properties. 2, 4 It acts through its receptors AdipoR1 and AdipoR2, in muscle and liver, respectively, stimulating adenosine monophosphate-activated protein kinase and the peroxisome proliferator-activated receptor-a pathways. 2, 4 It increases fatty acid oxidation, reduces circulating free fatty acids, and prevents insulin resistance. 4 Its levels are reduced in patients with type 2 DM and insulin resistance (compared with participants with normal glucose tolerance), as well as in those with coronary artery disease (CAD), nonalcoholic fatty liver disease, obesity, and high load of cardiometabolic risk factors. 2, 4, 5 A positive association between high-density lipoprotein cholesterol (HDL-C) and adiponectin levels and an inverse relationship with homeostatic model assessment insulin resistance (HOMA-IR) have been reported. 5 Adiponectin is the only adipokine that is downregulated in obesity. 2 The HMW adiponectin has also been inversely associated with the extent of atherosclerosis in males. Its levels are downregulated in patients with metabolic syndrome (MetS) and type 2 DM. 2 However, current evidence is not definitive enough to establish HMW as a better cardiometabolic risk marker than total adiponectin levels. 6 Most studies show an inverse association between adiponectin levels and incidence of CAD. This is more evident in patients with low risk for cardiovascular disease (CVD). 2, 6 On the other hand, some studies in patients with high CVD risk or established CAD have reported higher total adiponectin levels to be associated with higher mortality. 6 Except for the differences in the population characteristics, statistical adjustments, and analytical methods used in these studies, the higher levels of adiponectin in patients with high risk of CVD may be a compensatory physiological response to prevent endothelial damage. 6, 7 
Adiponectin Gene Polymorphisms and Risk for DM and MetS
The genetic basis of adiponectin levels has been thoroughly investigated during the last decade. The adiponectin (ADIPOQ) gene has been mostly studied and several SNPs have been identified. The most robust association between adiponectin levels and ADI-POQ locus that has emerged involves the variants À11391 G/A (rs17300539), À11377 C/G (rs266729), and À11426A>G (rs16861194) located in the promoter region, the þ45 T/G (rs2241766) variant in exon 2, the þ276 G/T (rs1501299) variant in intron 2 and the þ2019 single-nucleotide insertion/deletion polymorphism in the 3 0 untranslated region. 6, 8, 9 Several studies linked the aforementioned polymorphisms of ADIPOQ with the risk of CAD and type 2 DM in various populations. Studies from Asian populations have shown that SNP45GG genotype or G allele was a predictor of type 2 DM in Chinese and Japanese populations. 9, 10 There are inconsistent data about the SNP276G allele, since an association with increased risk of type 2 DM in Japanese 10 and in the elderly individuals from Taiwan 11 has been reported, but others found no association. 12 Some studies have also shown that SNP-11377GG genotype, SNP45G allele, SNP276GG genotype, and SNP712GG genotype might be a risk factor for dyslipidemia as they were associated with higher triglycerides (TGs), higher low-density lipoprotein cholesterol, lower HDL-C, and higher total cholesterol. 9 Regarding atherosclerosis, SNP-11377GG and SNP45TGþGG genotypes have been associated with increased carotid artery intima-media thickness in type 2 DM. 9 The association of ADIPOQ variants with insulin resistance was also reported in European cohorts. In particular, SNP þ276G>T but not SNP þ45T>G was associated with higher fasting insulin levels and HOMA-IR in nondiabetic Greek women, an effect which was evident in those with higher body fat status. 13 Both ADIPOQ À11377GG and À11391GA variants have also been associated with increased risk of central obesity (odds ratio [OR]: 5.57 and OR: 3.37, respectively) in a recent study of a young European population. Both À11377C>G and À11391G>A variants were also significantly associated with the incidence of MetS and high TG levels in the same study. 14 The ADIPOQ þ45T>G polymorphism and in particular the þ45G allele (TG þ GG) was significantly associated with increased risk of MetS (OR ¼ 1.88, 95% confidence interval [CI]: 1.03-3.44, P ¼ .039), independent of multiple confounders, in a recent study in a population of same origin (Asian) 15 as in the present study by Rizk et al. 1 Nevertheless, in a recent multiethnic population study (Diabetes Prevention Program), despite the strong independent associations of some ADIPOQ SNPs, such as rs17366568, rs1648707, rs17373414, and rs1403696, with adiponectin concentrations, none of them were directly related to the incidence of DM. However, 2 ADIPOR1 SNPs (rs1342387 and rs12733285) were associated with 18% increased DM incidence for carriers of the minor allele. 16 
Adiponectin Gene Polymorphisms and CVD
Except for the association of ADIPOQ variants with the risk of DM or MetS, there are several studies reporting associations of these polymorphisms with the risk of CVD (mainly CAD and stroke). In contrast to the findings of Rizk et al in this issue of Angiology, 1 larger studies from European 17 and Asian 18 populations have found that the SNP þ276G>T (but not SNP þ45T>G or other SNPs) was associated with CAD. In particular, in a large Italian cohort, TT homozygotes had half the risk of either myocardial infarction alone or myocardial infarction in association with type 2 DM (OR ¼ 0.58, P ¼ 0.01, and OR ¼ 0.55, P ¼ 0.006, respectively), when compared with the carriers of the G allele 17 ; while in a Japanese cohort the GG genotype was significantly associated with CVD, even after adjustment for traditional risk factors (OR ¼ 1.66 with 95% CI 1.13-2.43, P ¼ 0,0098). 18 In contrast, a study in a Chinese population showed that of the 3 SNPs [rs266729 (À11377C/G), rs2241766 (+45T/G), rs1501299 (+276G/T)] of the ADIPOQ gene, only the rs266729 and in particular the GG genotype was associated with an increased the risk of ischemic stroke. 19 Similar results as Rizk et al 1 regarding the association of þ45T>G (rs2241766) and the G allele with increased risk of CAD (OR: 2.45, 95% CI: 1.05-6.04, P ¼ .04) were obtained from a recent study in Brazilian participants with or without DM, although it was associated with higher levels of total and HMW adiponectin. 20 The authors of this study found that the G allele of þ276G>T (rs1501299) was also associated with increased risk of CAD. These associations were independent of circulating levels of adiponectin. 20 Two recent meta-analyses addressed the association of adiponectin gene polymorphisms with the risk of CVD, which yielded similar results for þ45T/G. The first one (including 4394 cases/8187 controls) showed a significant association between À11377C/G polymorphism and CAD (G vs C: OR ¼ 1.15, 95% CI: 1.07-1.24) both for European and East Asian populations, without any association with þ45T/G or þ276G/T SNPs. 21 Another meta-analysis including data from 12 465 participants from 17 case-control studies revealed an increased risk of CAD for rs266729 and rs822395 SNPs and a reduced risk of CAD for rs1501299 SNP. In the stratified analysis, significant associations were found in Asian participants for rs266729 and in Caucasian participants for rs1501299. However, no association with the risk of CAD was found for rs2241766 (þ45T/G). 22 These results were confirmed by another recent meta-analysis of case-control studies in the Chinese Han population which suggested that the SNPþ45T>G was not associated with CAD, in contrast to SNPþ276T allele which might be associated with decreased risk of CAD. 23 In contrast, in another meta-analysis of studies from the same population the SNPþ45T>G and in particular the G allele showed a trend toward an increased risk of type 2 DM, without any association with SNPþ276. 24 Finally, in another metaanalysis, only the G allele of À11377C>G (rs266729) was a risk factor for type 2 DM in white populations. 25 
